Low Doses of EPO Activate MAP Kinases but Not JAK2–STAT5 in Rat Vascular Smooth Muscle Cells
- 22 June 2001
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 284 (4), 1031-1038
- https://doi.org/10.1006/bbrc.2001.5085
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Signal Transduction in the Erythropoietin Receptor SystemExperimental Cell Research, 1999
- The effect of erythropoietin on interleukin-1β mediated increase in nitric oxide synthesis in vascular smooth muscle cellsJournal of Hypertension, 1999
- Human recombinant erythropoietin inhibits interleukin-1 -stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cellsNephrology Dialysis Transplantation, 1999
- Protein Kinase C-ζ Mediates Angiotensin II Activation of ERK1/2 in Vascular Smooth Muscle CellsOnline Journal of Public Health Informatics, 1997
- The Signal Transduction Pathway of Erythropoietin Involves Three Forms of Mitogen‐Activated Protein (MAP) Kinase in UT7 Erythroleukemia CellsJBIC Journal of Biological Inorganic Chemistry, 1995
- Activation of Mitogen-Activated Protein Kinase Cascade through Erythropoietin ReceptorBiochemical and Biophysical Research Communications, 1994
- Effect of Erythropoietin on DNA Synthesis, Proto-oncogene Expression and Phospholipase C Activity in Rat Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Erythropoietin induces the association of phosphatidylinositol 3′‐kinase with a tyrosine‐phosphorylated protein complex containing the erythropoietin receptorJBIC Journal of Biological Inorganic Chemistry, 1993
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- Endothelium-derived contracting factors.Hypertension, 1992